$VNS therapy for medically refractory partial seizures: An update$
QR Code

QR Code

VNS therapy for medically refractory partial seizures: An update

Enregistré dans:

Détails bibliographiques
Auteur principal:	James W. Wheless
Format:	article
Langue:	EN
Publié:	Elsevier 2021
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Accès en ligne:	https://doaj.org/article/267e21a74e9f4830a4e0420ba98cc47e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Predicting seizure response to VNS through connectomic profiling
par: George ibrahim
Publié: (2021)

Treatment of refractory complex partial seizures: role of vigabatrin
par: Elizabeth J Waterhouse, et autres
Publié: (2009)

Management of refractory complex partial seizures: current state of the art
par: David M Treiman
Publié: (2010)

Dopaminergic mechanisms of VNS-induced motor system plasticity
par: Catherine Thorn
Publié: (2021)

Parametric modulation of the heart and brain using transcutaneous auricular vagus nerve stimulation (taVNS)
par: Bashar Badran
Publié: (2021)

Diffusional kurtosis imaging reveals taVNS facilitates microstructural changes in the developing neonatal brain
par: Hunter Moss, et autres
Publié: (2021)

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report
par: Noda Y, et autres
Publié: (2014)

Effects of VNS paired with rehabilitation for chronic upper limb recovery post stroke: cross-over response
par: Teresa Kimberley, et autres
Publié: (2021)

At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
par: Sarah Huffman, et autres
Publié: (2021)

The effect of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) on hypoxic-ischemic injury in newborn rats
par: Melanie Wiley, et autres
Publié: (2021)

At-home telemedicine controlled taVNS twice daily for 4 weeks reduces long COVID symptoms of anxiety and fatigue
par: Christopher Austelle, et autres
Publié: (2021)

Predicting response to transcutaneous auricular vagus nerve stimulation (taVNS) paired with oromotor feeding in neonates: CNS metabolite biomarkers by MR spectroscopy (MRS)
par: Sally Hunt, et autres
Publié: (2021)

Increasing the number of daily stimulation sessions administered during taVNS-paired bottle feeding speeds response time in newborns with feeding difficulty
par: Lauren Adams, et autres
Publié: (2021)

Retrospective Review of Clinical Effects, Tolerability and Outcomes of Deep Brain Stimulation (DBS) and Vagal Nerve Stimulation (VNS) in Patients Aged 23 and Younger
par: Deniz Yuruk, et autres
Publié: (2021)

Lacosamide for the prevention of partial onset seizures in epileptic adults
par: Anna Kelemen, et autres
Publié: (2010)

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
par: Carol M Ulloa, et autres
Publié: (2009)

Quantitative ictal electroencephalography (qEEG) comparison of Focal Electrically-Administered Seizure Therapy (FEAST) and Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy (UBP-RUL ECT)
par: Kevin Caulfield, et autres
Publié: (2021)

Profile of perampanel and its potential in the treatment of partial onset seizures
par: Rheims S, et autres
Publié: (2013)

Tiagabine: efficacy and safety in partial seizures &ndash; current status
par: J&uuml;rgen Bauer, et autres
Publié: (2008)

Medial temporal seizures breakdown effective connectivity within the hippocampal network
par: Simone Russo, et autres
Publié: (2021)

Vagus nerve electroneurogram-based detection of acute pentylenetetrazol induced seizures in rats
par: Lars Stumpp, et autres
Publié: (2021)

Gelastic seizures associated with hypothalamic hamartomas. An update in the clinical presentation, diagnosis and treatment
par: Jos&eacute; F. Tellez-Zenteno, et autres
Publié: (2008)

Update on treatment of partial onset epilepsy: role of eslicarbazepine
par: Markus Rauchenzauner, et autres
Publié: (2010)

Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
par: Weisenberg JLZ, et autres
Publié: (2011)

Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
par: Cormier J, et autres
Publié: (2013)

Reliability of TMS-derived hand motor mapping across development in clinical cohort with refractory epilepsy or brain tumor
par: Mia Fox, et autres
Publié: (2021)

Treatment of refractory obsessive-compulsive disorder with comorbid major depression with sequential multi-locus transcranial magnetic stimulation
par: Reza Tadayonnejad, et autres
Publié: (2021)

The mechanisms of action of vagus nerve stimulation in difficult-to-treat depression: An update
par: Harold Sackeim
Publié: (2021)

Long‐term continuation of anti‐seizure medications after acute stroke
par: Vineet Punia, et autres
Publié: (2021)

Variability in TMS-EEG response can partially be described by the phase of ongoing brain oscillation
par: Mohsen Poorganji, et autres
Publié: (2021)

The Emerging Role of Scalogram-Based Convolutional Neural Network in the Diagnosis of Epileptic Seizures
par: Evanthia Bernitsas
Publié: (2021)

Nonepileptic seizures under levetiracetam therapy: a case report of forced normalization process
par: Anzellotti F, et autres
Publié: (2014)

Clobazam as an adjunctive therapy in treating seizures associated with Lennox&ndash;Gastaut syndrome
par: Leahy JT, et autres
Publié: (2011)

Real world evidence of age-independent electroconvulsive therapy efficacy: a retrospective cohort study
par: James Luccarelli, et autres
Publié: (2021)

Vagus nerve stimulation in patients receiving maintenance therapy with electroconvulsive therapy: a series of 10 cases
par: Scott Aaronson, et autres
Publié: (2021)

Current state of electromagnetic neuromodulation therapy
par: Mark S. George
Publié: (2021)

Current state of ultrasound neuromodulation therapy
par: Roland Beisteiner
Publié: (2021)

Cellular mechanisms of electromagnetic neuromodulation therapy
par: Vincenzo DiLazzaro
Publié: (2021)

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
par: Manoj K. Doss, et autres
Publié: (2021)

The effectiveness of non-clozapine antipsychotics combined with electroconvulsive therapy versus clozapine combined with electroconvulsive therapy for treatment-resistant schizophrenia
par: Pichai Ittasakul, et autres
Publié: (2021)